An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Комплексный геномный анализ мультиформной глиобластомы человека
2008-09-04
SCID: 54.1/qufgnqys
Discuss with AI
Copy number alterationsGene expression analysisGlioblastoma multiformeIDH1 mutationsIntegrated genomic analysis
Figures from the paper
Abstract (AI)
Glioblastoma multiforme (GBM) is the most common and lethal type of brain cancer. To identify the genetic alterations in GBMs, we sequenced 20,661 protein coding genes, determined the presence of amplifications and deletions using high-density oligonucleotide arrays, and performed gene expression analyses using next-generation sequencing technologies in 22 human tumor samples. This comprehensive analysis led to the discovery of a variety of genes that were not known to be altered in GBMs. Most notably, we found recurrent mutations in the active site of isocitrate dehydrogenase 1 (IDH1) in 12% of GBM patients. Mutations in IDH1 occurred in a large fraction of young patients and in most patients with secondary GBMs and were associated with an increase in overall survival. These studies demonstrate the value of unbiased genomic analyses in the characterization of human brain cancer and identify a potentially useful genetic alteration for the classification and targeted therapy of GBMs.
Key Findings
1
An integrated analysis of 22 human GBM tumors combined sequencing of 20,661 protein-coding genes, copy-number profiling, and gene-expression analysis.
2
IDH1 mutations were associated with increased overall survival, supporting their potential use in GBM classification and targeted therapy.
3
IDH1 mutations were frequent among younger patients and present in most secondary GBMs.
4
Recurrent mutations in the active site of IDH1 occurred in 12% of GBM patients.
5
The comprehensive genomic analysis identified multiple genes not previously known to be altered in glioblastoma multiforme.
Research Object
human glioblastoma multiforme (GBM) tumors
Research Subject
genetic alterations, particularly recurrent IDH1 active-site mutations and their associations with patient age, secondary GBM status, overall survival, classification, and targeted therapy
Publication Details
Publication Date
2008-09-04
Journal
Science
Publisher
American Association for the Advancement of Science
ISSN
0036-8075
Cited by
6501
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by16
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation2009
Mutational landscape and significance across 12 major cancer types2013
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas2015
The epidemiology of glioma in adults: a "state of the science" review2014
International network of cancer genome projects2010
Glioblastoma and Other Primary Brain Malignancies in Adults2023
Multimodal biomedical AI2022
The Definition of Primary and Secondary Glioblastoma2012
Glutaminolysis: A Hallmark of Cancer Metabolism2017
Metabolic reprogramming and epigenetic modifications on the path to cancer2021
Adult Glioblastoma2017
Glioma targeted therapy: insight into future of molecular approaches2022
Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas2012
Metabolism of Amino Acids in Cancer2021
Using the molecular classification of glioblastoma to inform personalized treatment2013
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing2012